Preclinical News and Research

RSS
Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Death of heart tissue could be prevented with new medicines, say TUSM scientists

Death of heart tissue could be prevented with new medicines, say TUSM scientists

ATSP-9172 exhibits on-target binding activity in human prostate cancer model

ATSP-9172 exhibits on-target binding activity in human prostate cancer model

Androgen receptors found to be a potential target in breast cancer

Androgen receptors found to be a potential target in breast cancer

Modulation of cerebral endocannabinoid system may help treat Fragile X chromosome syndrome

Modulation of cerebral endocannabinoid system may help treat Fragile X chromosome syndrome

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

OncoMed highlights progress of anti-cancer biologics at AACR annual meeting

Pharmacyclics presents positive results of ibrutinib Phase II trial in untreated, relapsed and refractory CLL patients

Pharmacyclics presents positive results of ibrutinib Phase II trial in untreated, relapsed and refractory CLL patients

New data on use of PBD dimers as warheads in ADCs presented at AACR annual meeting

New data on use of PBD dimers as warheads in ADCs presented at AACR annual meeting

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

ImmunoGen discloses preclinical data for EGFR-targeting ADC, IMGN289

ImmunoGen discloses preclinical data for EGFR-targeting ADC, IMGN289

Data on PV-10 combination therapy presented at AACR Annual Meeting

Data on PV-10 combination therapy presented at AACR Annual Meeting

Preclinical study of cabozantinib in prostate cancer bone metastasis model presented at AACR meeting

Preclinical study of cabozantinib in prostate cancer bone metastasis model presented at AACR meeting

New study suggests that Ranibizumab can be potential prophylaxis for PVR

New study suggests that Ranibizumab can be potential prophylaxis for PVR

Researchers design drug to block incidence of head, neck cancer caused by HPV virus

Researchers design drug to block incidence of head, neck cancer caused by HPV virus

Study: Chicken-killing virus is a promising treatment for prostate cancer

Study: Chicken-killing virus is a promising treatment for prostate cancer

Absorption Systems, Synerzys Lifecare partner to expand use of Biopharmaceutics Classification System

Absorption Systems, Synerzys Lifecare partner to expand use of Biopharmaceutics Classification System

Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment

Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment

ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013

ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013

Clinical data of two Transgene products to be presented at EASL Conference

Clinical data of two Transgene products to be presented at EASL Conference

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.